Pilot evaluation of a brief intervention to improve nicotine patch adherence among smokers living with HIV/AIDS
- PMID: 27736144
- PMCID: PMC5344742
- DOI: 10.1037/adb0000221
Pilot evaluation of a brief intervention to improve nicotine patch adherence among smokers living with HIV/AIDS
Abstract
Nicotine replacement therapy is an effective intervention for smoking cessation, but adherence tends to be low. This article presents results from a pilot evaluation of a brief smoking cessation treatment to improve adherence to the nicotine patch among Latino smokers living with HIV/AIDS. Forty smokers were randomized to receive either a standard 5 As counseling session and 8-week treatment of nicotine patch, or a similar intervention that added a 10-min module to the 5 As counseling that focused on improving adherence to the nicotine patch. Smoking outcomes (breath carbon monoxide monitoring verified 7-day point prevalence and continuous abstinence) were evaluated through a 3-month follow-up. Patch usage during the follow-up period was also assessed. Intention to treat analyses indicated that abstinence rates were 2 to 3 times higher in the adherence condition compared with the standard condition (7-day point prevalence abstinence: 35.0% vs. 15.0%; continuous abstinence: 30.0% vs. 10.0%). Nicotine patch compliance over an 8-week period was also higher in the adherence condition than in the standard condition (44% vs. 25%). Although this small pilot was conducted to estimate effect sizes and was not powered to detect group differences, results are promising and suggest that adding a 10-min module focused on nicotine patch adherence to a standard 5 As protocol can increase abstinence rates. Given that this smoking cessation treatment was not specifically tailored to either HIV-positive smokers or Latino smokers, future research should examine whether it may be a promising approach for improving nicotine patch adherence in the general population of smokers. (PsycINFO Database Record
(c) 2017 APA, all rights reserved).
Similar articles
-
Effects of Nicotine Patch vs Varenicline vs Combination Nicotine Replacement Therapy on Smoking Cessation at 26 Weeks: A Randomized Clinical Trial.JAMA. 2016 Jan 26;315(4):371-9. doi: 10.1001/jama.2015.19284. JAMA. 2016. PMID: 26813210 Free PMC article. Clinical Trial.
-
Varenicline versus nicotine patch with brief advice for smokers with substance use disorders with or without depression: effects on smoking, substance use and depressive symptoms.Addiction. 2017 Oct;112(10):1808-1820. doi: 10.1111/add.13861. Epub 2017 Jul 4. Addiction. 2017. PMID: 28498504 Clinical Trial.
-
The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study.Drug Alcohol Depend. 2015 Aug 1;153:271-7. doi: 10.1016/j.drugalcdep.2015.05.007. Epub 2015 May 18. Drug Alcohol Depend. 2015. PMID: 26051163 Free PMC article. Clinical Trial.
-
Smoking and HIV: prevalence, health risks, and cessation strategies.Curr HIV/AIDS Rep. 2012 Sep;9(3):223-30. doi: 10.1007/s11904-012-0121-0. Curr HIV/AIDS Rep. 2012. PMID: 22618079 Review.
-
Assessing outcome in smoking cessation studies.Psychol Bull. 1992 Jan;111(1):23-41. doi: 10.1037/0033-2909.111.1.23. Psychol Bull. 1992. PMID: 1539088 Review.
Cited by
-
Interventions for tobacco use cessation in people living with HIV.Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3. Cochrane Database Syst Rev. 2024. PMID: 39101506 Review.
-
Identifying determinants of varenicline adherence using the Theoretical Domains framework: a rapid review.BMC Public Health. 2024 Mar 4;24(1):679. doi: 10.1186/s12889-024-18139-z. BMC Public Health. 2024. PMID: 38438884 Free PMC article. Review.
-
Using the Behaviour Change Wheel and modified Delphi method to identify behavioural change techniques for improving adherence to smoking cessation medications.BMC Public Health. 2023 Jul 17;23(1):1362. doi: 10.1186/s12889-023-16278-3. BMC Public Health. 2023. PMID: 37455312 Free PMC article.
-
Medication Adherence in Tobacco Cessation Clinical Trials.Addict Neurosci. 2023 Jun;6:100069. doi: 10.1016/j.addicn.2023.100069. Epub 2023 Jan 31. Addict Neurosci. 2023. PMID: 36817408 Free PMC article.
-
Attitudes and practices of health care providers towards improving adherence to smoking cessation medications in Australia: A descriptive study.Health Promot J Austr. 2023 Oct;34(4):848-855. doi: 10.1002/hpja.674. Epub 2022 Nov 1. Health Promot J Austr. 2023. PMID: 36284364 Free PMC article.
References
-
- Baker T, Piper ME, McCarthy DE, Bolt DM, Smith SS, Kim S … Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence Phenotype Workgroup. Time to first cigarette in the morning as an index of ability to quit smoking: Implications for nicotine dependence. Nicotine & Tobacco Research. 2007;9:S555–S570. - PMC - PubMed
-
- Biener L, Abrams DB. The Contemplation Ladder: Validation of a measure of readiness to consider smoking cessation. Health Psychology. 1991;10:360–365. - PubMed
-
- Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, … Wewers ME. Treating tobacco use and dependence: 2008 update. Quick reference guide for clinicians. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
